Streetbeat News

Price Targets

DRTS

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Alpha Tau Medical (NASDAQ:DRTS) and maintained a $23 price target.

Portfolio Pulse from richadhand@benzinga.com

August 29, 2023 | 2:24 pm

DG

Oppenheimer analyst Rupesh Parikh maintains an Outperform rating on Dollar General (NYSE:DG) but has lowered the price target from $200 to $195.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 2:22 pm

AVGO

Piper Sandler analyst Harsh Kumar maintains an Overweight rating on Broadcom (NASDAQ:AVGO) and raises the price target from $830 to $925.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 2:21 pm

SMMF

DA Davidson analyst Manuel Navas maintains a Neutral rating on Summit Financial Group (NASDAQ:SMMF) and raises the price target from $25 to $27.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 2:18 pm

HT

Baird analyst Michael Bellisario maintains a Neutral rating on Hersha Hospitality (NYSE:HT) and raises the price target from $7 to $10.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 2:14 pm

BB

Baird analyst Luke Junk maintains a Neutral rating on BlackBerry (NYSE:BB) and raises the price target from $5.5 to $6.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 2:13 pm

KNTK

Scotiabank analyst Tristan Richardson maintains an Outperform rating on Kinetik Holdings (NYSE:KNTK) and raises the price target from $37 to $39.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 2:12 pm

PR

Citigroup analyst Paul Diamond maintains a Buy rating on Permian Resources (NYSE:PR) and raises the price target from $14 to $16.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 2:09 pm

BIIB

RBC Capital analyst Brian Abrahams has maintained an 'Outperform' rating on Biogen (NASDAQ:BIIB) and raised the price target from $354 to $357.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 2:07 pm

NVCR

Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on NovoCure (NASDAQ:NVCR) but lowered the price target from $102 to $49.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 2:02 pm